Placebo-2: Clinical Trials

2 trials of Placebo-2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 unknown. 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 11Terminated 1

Follow Placebo-2: new trials by email Literature Review of Placebo-2 trials Research Report on Placebo-2

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti-age Dietary Supplements in Healthy Older Adults: the proBNPage Reduction Trial
Coenzyme Q10, Selenium, Resveratrol - Aging
Not applicableUnknownIRCCS Azienda Ospedaliero-Universitaria di Bologna1202022-07-222023-02-02
Dose Escalating Study of CCI15106 Inhalation Capsules in Healthy Subjects and Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients
CCI15106 7.5 mg capsule, Placebo, Placebo-2 - Pulmonary Disease, Chronic Obstructive
Phase 1TerminatedGlaxoSmithKline602016-02-102020-06-30

Conditions studied

Pulmonary Disease, Chronic Obstructive (1)

Sponsors

GlaxoSmithKline (1)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (1)

Countries

Italy (1)  ·  United Kingdom (1)

Top investigators

Paola Forti, MD (1)

Results publications

PMID 32071044, PMID 37915546

NIH funding

2015 (1)